You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Medtronic
Mallinckrodt
Express Scripts
McKesson

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE (EMOLLIENT) Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Clobetasol Propionate (emollient) patents expire, and when can generic versions of Clobetasol Propionate (emollient) launch?

Clobetasol Propionate (emollient) is a drug marketed by Fougera Pharms, Ingenus Pharms Llc, Taro, and Teligent Pharma Inc. and is included in four NDAs.

The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

US ANDA Litigation and Generic Entry Outlook for Clobetasol Propionate (emollient)

A generic version of CLOBETASOL PROPIONATE (EMOLLIENT) was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Start Trial

Summary for CLOBETASOL PROPIONATE (EMOLLIENT)
Drug patent expirations by year for CLOBETASOL PROPIONATE (EMOLLIENT)
Pharmacology for CLOBETASOL PROPIONATE (EMOLLIENT)

US Patents and Regulatory Information for CLOBETASOL PROPIONATE (EMOLLIENT)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075430-001 May 26, 1999 AB2 RX No Yes   Start Trial   Start Trial   Start Trial
Teligent Pharma Inc CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411-001 Aug 21, 2017 AB2 RX No No   Start Trial   Start Trial   Start Trial
Ingenus Pharms Llc CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075733-001 Aug 22, 2001 AB2 RX No No   Start Trial   Start Trial   Start Trial
Taro CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075633-001 May 17, 2000 AB2 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Moodys
Boehringer Ingelheim
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.